Legend Biotech (LEGN) EBT (QoQ) (2019 - 2025)
Legend Biotech (LEGN) EBT (QoQ) (2019 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Regeneron Pharmaceuticals | 63.60 Bn | 54.85 Bn | 3.31 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 150.16% |
| Sep 30, 2025 | 68.69% |
| Jun 30, 2025 | -25.89% |
| Mar 31, 2025 | -344.77% |
| Dec 31, 2024 | 133.50% |
| Sep 30, 2024 | -572.71% |
| Jun 30, 2024 | 69.94% |
| Mar 31, 2024 | 59.28% |
| Dec 31, 2023 | -134.92% |
| Sep 30, 2023 | 68.57% |
| Jun 30, 2023 | -77.58% |
| Mar 31, 2023 | 17.50% |
| Dec 31, 2022 | -60.04% |
| Sep 30, 2022 | 56.08% |
| Jun 30, 2022 | -500.98% |
| Mar 31, 2022 | 63.63% |
| Dec 31, 2021 | 29.19% |
| Sep 30, 2021 | -36.22% |
| Jun 30, 2021 | -96,707.71% |
| Mar 31, 2021 | 99.84% |